Romero J et al. |
The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior: role of nigrostriatal dopaminergic neurons. |
1995 |
Life Sci. |
pmid:7776829
|
Adams IB et al. |
Pharmacological and behavioral evaluation of alkylated anandamide analogs. |
1995 |
Life Sci. |
pmid:7776830
|
Wenger T et al. |
Effects of anandamide (endogen cannabinoid) on anterior pituitary hormone secretion in adult ovariectomized rats. |
1995 |
Life Sci. |
pmid:7776832
|
Cabral GA et al. |
Anandamide inhibits macrophage-mediated killing of tumor necrosis factor-sensitive cells. |
1995 |
Life Sci. |
pmid:7776833
|
Wiley J et al. |
Discriminative stimulus effects of anandamide in rats. |
1995 |
Eur. J. Pharmacol. |
pmid:7781695
|
Barg J et al. |
Cannabinomimetic behavioral effects of and adenylate cyclase inhibition by two new endogenous anandamides. |
1995 |
Eur. J. Pharmacol. |
pmid:8749028
|
Terranova JP et al. |
Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors. |
1995 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:8751088
|
Burstein SH and Hunter SA |
Stimulation of anandamide biosynthesis in N-18TG2 neuroblastoma cells by delta 9-tetrahydrocannabinol (THC). |
1995 |
Biochem. Pharmacol. |
pmid:7702643
|
Priller J et al. |
Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors. |
1995 |
Mol. Pharmacol. |
pmid:7651362
|
Pertwee RG et al. |
Effect of phenylmethylsulphonyl fluoride on the potency of anandamide as an inhibitor of electrically evoked contractions in two isolated tissue preparations. |
1995 |
Eur. J. Pharmacol. |
pmid:7713152
|